← Back
$AVDL All transactions

AVADEL PHARMACEUTICALS PLC

▼ SELL

$ Value

$233.4M

Shares

11,112,052

Price

$21

Filed

Feb 18

Insider

Name

Weiss Asset Management LP

Title

CIK

0001357550

Roles

Other

Transaction Details

Transaction Date

2026-02-13

Code

S

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

Footnotes

Represents the cash portion of the consideration paid to shareholders upon the closing of the acquisition of the Issuer by Alkermes plc. In connection with such transaction, each outstanding share was automatically converted into the right to receive $21.00 per share in cash, plus a contingent value right to receive a payment of $1.50 in cash if a specified milestone is achieved. | Shares reported herein represent shares beneficially owned by two private investment funds for which Weiss Asset Management LP serves as investment manager. WAM GP LLC is the general partner of Weiss Asset Management LP and Andrew Weiss is the Manager of WAM GP LLC. All of Weiss Asset Management LP, WAM GP LLC, and Andrew Weiss disclaim beneficial ownership of the shares reported herein except to the extent of their pecuniary interest therein.

Filing Info

Accession No.

0001357550-26-000015

Form Type

4

Issuer CIK

0001012477

Weiss Asset Management LP's History

Date Ticker Type Value
2026-02-13 AVDL $233.4M

Other Insiders at AVDL (90d)

Insider Bought Sold Last
MCHUGH THOMAS S
Chief Financial Officer
2026-02-12
Thornton Peter J. 2026-02-12
McCamish Mark Anthony 2026-02-12
Divis Gregory J
Chief Executive Officer
2026-02-12
Ende Eric J 2026-02-12
Glass Geoffrey Michael 2026-02-12
Amin Naseem 2026-02-12
Palczuk Linda 2026-02-12
Rodriguez Susan
Chief Operating Officer
2026-02-12
Seurer Jerad G.
Gen. Counsel & Corp. Secretary
2026-02-12